319 related articles for article (PubMed ID: 11737582)
21. Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis.
Garringer HJ; Malekpour M; Esteghamat F; Mortazavi SM; Davis SI; Farrow EG; Yu X; Arking DE; Dietz HC; White KE
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E929-37. PubMed ID: 18682534
[TBL] [Abstract][Full Text] [Related]
22. Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets.
Imel EA; Liu Z; Coffman M; Acton D; Mehta R; Econs MJ
J Bone Miner Res; 2020 Feb; 35(2):231-238. PubMed ID: 31652009
[TBL] [Abstract][Full Text] [Related]
23. Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: A review of the role of iron.
Menon LP; Weinstein RS
Bone; 2020 Feb; 131():115137. PubMed ID: 31756522
[TBL] [Abstract][Full Text] [Related]
24. Autosomal Dominant Hypophosphatemic Rickets: A Case Report and Review of the Literature.
Mameli C; Sangiorgio A; Colombo V; Gambino M; Spaccini L; Cattaneo E; Zuccotti GV
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444516
[TBL] [Abstract][Full Text] [Related]
25. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
Wolf M; White KE
Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):411-9. PubMed ID: 24867675
[TBL] [Abstract][Full Text] [Related]
26. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets.
Sun Y; Wang O; Xia W; Jiang Y; Li M; Xing X; Hu Y; Liu H; Meng X; Zhou X
J Bone Miner Metab; 2012 Jan; 30(1):78-84. PubMed ID: 21710177
[TBL] [Abstract][Full Text] [Related]
27. Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets.
Liu C; Li X; Zhao Z; Chi Y; Cui L; Zhang Q; Ping F; Chai X; Jiang Y; Wang O; Li M; Xing X; Xia W
Osteoporos Int; 2021 Apr; 32(4):737-745. PubMed ID: 32995940
[TBL] [Abstract][Full Text] [Related]
28. Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13.
Econs MJ; McEnery PT; Lennon F; Speer MC
J Clin Invest; 1997 Dec; 100(11):2653-7. PubMed ID: 9389727
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin.
Fukumoto S; Yamashita T
Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):385-9. PubMed ID: 12105387
[TBL] [Abstract][Full Text] [Related]
30. A familial disorder with low bone density and renal phosphate wasting.
Grondel IM; van der Deure J; Zanen AL; Dogger M; van den Heuvel LP
Eur J Intern Med; 2009 Sep; 20(5):503-8. PubMed ID: 19712854
[TBL] [Abstract][Full Text] [Related]
31. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.
Yamazaki Y; Okazaki R; Shibata M; Hasegawa Y; Satoh K; Tajima T; Takeuchi Y; Fujita T; Nakahara K; Yamashita T; Fukumoto S
J Clin Endocrinol Metab; 2002 Nov; 87(11):4957-60. PubMed ID: 12414858
[TBL] [Abstract][Full Text] [Related]
32. [Hereditary hypophosphatemia in adults].
Vélayoudom-Céphise FL; Vantyghem MC; Wémeau JL
Presse Med; 2005 Dec; 34(22 Pt 1):1720-6. PubMed ID: 16374396
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed.
Larsson T; Davis SI; Garringer HJ; Mooney SD; Draman MS; Cullen MJ; White KE
Endocrinology; 2005 Sep; 146(9):3883-91. PubMed ID: 15961556
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 23 and its receptors.
Yu X; White KE
Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
[TBL] [Abstract][Full Text] [Related]
35. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.
Larsson T; Marsell R; Schipani E; Ohlsson C; Ljunggren O; Tenenhouse HS; Jüppner H; Jonsson KB
Endocrinology; 2004 Jul; 145(7):3087-94. PubMed ID: 14988389
[TBL] [Abstract][Full Text] [Related]
36. [Phosphate metabolism and iron deficiency].
Yokoyama K
Clin Calcium; 2016 Feb; 26(2):241-9. PubMed ID: 26813504
[TBL] [Abstract][Full Text] [Related]
37. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
Bielesz B
Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
[TBL] [Abstract][Full Text] [Related]
38. [Autosomal dominant hypophosphatemic rickets].
Yamamoto T
Nihon Rinsho; 2006 Jun; Suppl 2():116-9. PubMed ID: 16817364
[No Abstract] [Full Text] [Related]
39. Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation.
Kruse K; Woelfel D; Strom TM
Horm Res; 2001; 55(6):305-8. PubMed ID: 11805436
[TBL] [Abstract][Full Text] [Related]
40. A clinical and molecular genetic study of hypophosphatemic rickets in children.
Cho HY; Lee BH; Kang JH; Ha IS; Cheong HI; Choi Y
Pediatr Res; 2005 Aug; 58(2):329-33. PubMed ID: 16055933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
